Spots Global Cancer Trial Database for cohort 1 not previously treated
Every month we try and update this database with for cohort 1 not previously treated cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Abemaciclib and Pembrolizumab in Metastatic or Recurrent Head and Neck Cancer | NCT03938337 | Head and Neck C... | Cohort 1 Not Pr... Cohort 2 Treate... | 18 Years - | University of Alabama at Birmingham |